Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.

Awasthi S, Balliet JW, Flynn JA, Lubinski JM, Shaw CE, DiStefano DJ, Cai M, Brown M, Smith JF, Kowalski R, Swoyer R, Galli J, Copeland V, Rios S, Davidson RC, Salnikova M, Kingsley S, Bryan J, Casimiro DR, Friedman HM.

J Virol. 2014 Feb;88(4):2000-10. doi: 10.1128/JVI.03163-13. Epub 2013 Nov 27.

2.

Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread.

Awasthi S, Zumbrun EE, Si H, Wang F, Shaw CE, Cai M, Lubinski JM, Barrett SM, Balliet JW, Flynn JA, Casimiro DR, Bryan JT, Friedman HM.

J Virol. 2012 Apr;86(8):4586-98. doi: 10.1128/JVI.07203-11. Epub 2012 Feb 8.

3.

Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone.

Awasthi S, Lubinski JM, Shaw CE, Barrett SM, Cai M, Wang F, Betts M, Kingsley S, Distefano DJ, Balliet JW, Flynn JA, Casimiro DR, Bryan JT, Friedman HM.

J Virol. 2011 Oct;85(20):10472-86. doi: 10.1128/JVI.00849-11. Epub 2011 Aug 3.

4.

The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo.

Lubinski JM, Lazear HM, Awasthi S, Wang F, Friedman HM.

J Virol. 2011 Apr;85(7):3239-49. doi: 10.1128/JVI.02509-10. Epub 2011 Jan 12.

5.

Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine.

Awasthi S, Lubinski JM, Friedman HM.

Vaccine. 2009 Nov 16;27(49):6845-53. doi: 10.1016/j.vaccine.2009.09.017. Epub 2009 Sep 15.

6.

Herpes simplex virus type 1 infection increases the carbohydrate binding activity and the secretion of cellular galectin-3.

King RD, Lubinski JM, Friedman HM.

Arch Virol. 2009;154(4):609-18. doi: 10.1007/s00705-009-0351-7. Epub 2009 Mar 17.

PMID:
19291362
7.

A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine.

Brittle EE, Wang F, Lubinski JM, Bunte RM, Friedman HM.

J Virol. 2008 Sep;82(17):8431-41. doi: 10.1128/JVI.00551-08. Epub 2008 Jun 18.

8.

An HSV-1 gD mutant virus as an entry-impaired live virus vaccine.

Awasthi S, Lubinski JM, Eisenberg RJ, Cohen GH, Friedman HM.

Vaccine. 2008 Feb 26;26(9):1195-203. doi: 10.1016/j.vaccine.2007.12.032. Epub 2008 Jan 14.

9.
10.
11.
12.

Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection.

Judson KA, Lubinski JM, Jiang M, Chang Y, Eisenberg RJ, Cohen GH, Friedman HM.

J Virol. 2003 Dec;77(23):12639-45.

13.

Herpes simplex virus type 1 evades the effects of antibody and complement in vivo.

Lubinski JM, Jiang M, Hook L, Chang Y, Sarver C, Mastellos D, Lambris JD, Cohen GH, Eisenberg RJ, Friedman HM.

J Virol. 2002 Sep;76(18):9232-41.

14.

Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo.

Lubinski JM, Wang L, Soulika AM, Burger R, Wetsel RA, Colten H, Cohen GH, Eisenberg RJ, Lambris JD, Friedman HM.

J Virol. 1998 Oct;72(10):8257-63.

15.

The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge.

Peng T, Ponce-de-Leon M, Jiang H, Dubin G, Lubinski JM, Eisenberg RJ, Cohen GH.

J Virol. 1998 Jan;72(1):65-72.

16.

Combined chronic low dose radiation-caloric restriction: a model for regression of spontaneous mammary tumor.

Kharazi AI, James SJ, Taylor JM, Lubinski JM, Nakamura LT, Makinodan T.

Int J Radiat Oncol Biol Phys. 1994 Feb 1;28(3):641-7.

PMID:
8113107
17.

Double-negative (L3T4-, Lyt2-) thymocytes of autoimmune lpr/lpr mice are resistant to down-regulation of DNA synthesis by a thymic stromal cell product.

Lubinski JM, James SJ, Nakamura LT, Serrano-Williams A, Munekata MT, Ho SC, Chung JC, Makinodan T.

Cell Immunol. 1993 Sep;150(2):425-38.

PMID:
8370081
18.
19.

Primer-dependent synthesis of covalently linked dimeric RNA molecules by poliovirus replicase.

Lubinski JM, Ransone LJ, Dasgupta A.

J Virol. 1987 Oct;61(10):2997-3003.

20.

Mechanism of in vitro synthesis of covalently linked dimeric RNA molecules by the poliovirus replicase.

Lubinski JM, Kaplan G, Racaniello VR, Dasgupta A.

J Virol. 1986 May;58(2):459-67.

Supplemental Content

Loading ...
Support Center